Larimar Therapeutics Insider Trades
NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 17 · $26.12M
- Sales
- 0 · $0
- Shares bought / sold
- 5.31M / 0
- Net activity
- Net buying $26.1 million
Larimar Therapeutics insider activity
Over the last 12 months, Larimar Therapeutics insiders reported 22 transactions on SEC Form 4: 17 open-market purchases and 0 sales. Insiders bought $26.1 million and sold $0 worth of stock, for net insider buying of $26.1 million. The most recent filing shows Clayton Russell (Chief Medical Officer) buying 3,322 shares at $3.01 on Nov 16, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put LRMR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
LRMR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 16, 2026 | SHERMAN JEFFREY WDirector | Buy | 3,289 | $10.06K | Form 4 |
| Nov 16, 2026 | Clayton RussellChief Medical Officer | Buy | 3,322 | $10.00K | Form 4 |
| Nov 12, 2026 | Hamilton Thomas EdwardDirector | Buy | 70,000 | $187.08K | Form 4 |
| Nov 11, 2026 | Harlow John B. Jr.President and COO | Buy | 17,800 | $49.92K | Form 4 |
| Nov 11, 2026 | Truitt JosephDirector | Buy | 3,500 | $9.79K | Form 4 |
| Nov 11, 2026 | THOMAS FRANK EDirector | Buy | 8,000 | $21.80K | Form 4 |
| Nov 11, 2026 | BEN-MAIMON CAROLEPresident and CEO | Buy | 18,050 | $49.95K | Form 4 |
| Nov 11, 2026 | Shankar GopiChief Development Officer | Buy | 5,000 | $13.55K | Form 4 |
| Nov 11, 2026 | Celano MichaelChief Financial Officer | Buy | 18,460 | $49.99K | Form 4 |
| Sep 29, 2026 | Harlow John B. Jr.President and COO | Award | 50,000 | — | Form 4 |
| Jul 6, 2026 | Hamilton Thomas EdwardDirector | Buy | 50,000 | $166.89K | Form 4 |
| Feb 27, 2026 | SHERMAN JEFFREY WDirector | Buy | 5,000 | $25.00K | Form 4 |
| Feb 27, 2026 | THOMAS FRANK EDirector | Buy | 5,000 | $25.00K | Form 4 |
| Feb 27, 2026 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 2,000,000 | $10.00M | Form 4 |
| Feb 27, 2026 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 831,978 | $4.16M | Form 4 |
| Feb 27, 2026 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 1,084,012 | $5.42M | Form 4 |
| Feb 27, 2026 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 1,084,010 | $5.42M | Form 4 |
| Feb 27, 2026 | Hamilton Thomas EdwardDirector | Buy | 100,000 | $500.00K | Form 4 |
| Jan 26, 2026 | Clayton RussellChief Medical Officer | Award | 25,637 | — | Form 4 |
| Jan 26, 2026 | Celano MichaelChief Financial Officer | Award | 37,604 | — | Form 4 |
| Jan 26, 2026 | BEN-MAIMON CAROLEPresident and CEO | Award | 100,100 | — | Form 4 |
| Jan 26, 2026 | Shankar GopiChief Development Officer | Award | 25,637 | — | Form 4 |
| Jul 31, 2025 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 2,599,932 | $8.32M | Form 4 |
| Jul 31, 2025 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 3,387,539 | $10.84M | Form 4 |
| Jul 31, 2025 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 3,387,529 | $10.84M | Form 4 |
| Jan 22, 2025 | BEN-MAIMON CAROLEPresident and CEO | Award | 91,000 | — | Form 4 |
| Jan 22, 2025 | Clayton RussellChief Medical Officer | Award | 23,306 | — | Form 4 |
| Jan 22, 2025 | Celano MichaelChief Financial Officer | Award | 34,185 | — | Form 4 |
| Jan 22, 2025 | Shankar GopiChief Development Officer | Award | 23,306 | — | Form 4 |
| Feb 16, 2024 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 1,430,205 | $12.50M | Form 4 |
| Feb 16, 2024 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 1,430,206 | $12.50M | Form 4 |
| Feb 16, 2024 | Flynn James E & DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) & Deerfield Mgmt III, L.P. & Deerfield Mgmt HIF, L.P. & Deerfield Mgmt IV, L.P. & Deerfield Mgmt L.P. & Deerfield Private Design Fund III, L.P. & Deerfield Healthcare Innovations Fund, L.P. & Deerfield Private Design Fund IV, L.P. & DEERFIELD PARTNERS, L.P.Director | Buy | 1,430,206 | $12.50M | Form 4 |
| Feb 16, 2024 | Hamilton Thomas EdwardDirector | Buy | 57,208 | $500.00K | Form 4 |
| Feb 14, 2024 | THOMAS FRANK EDirector | Buy | 2,000 | $22.00K | Form 4 |
| Jan 17, 2024 | BEN-MAIMON CAROLEPresident and CEO | Award | 66,125 | — | Form 4 |
| Jan 17, 2024 | Clayton RussellChief Medical Officer | Award | 22,500 | — | Form 4 |
| Jan 17, 2024 | Celano MichaelChief Financial Officer | Award | 31,250 | — | Form 4 |
| Jan 17, 2024 | Shankar GopiChief Development Officer | Award | 22,500 | — | Form 4 |
| Dec 7, 2023 | Shankar GopiChief Development Officer | Buy | 5,000 | $18.66K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4